ETF Managers Group’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-7,621
| Closed | -$424K | – | 661 |
|
|
2021
Q1 | $424K | Buy |
7,621
+1,361
| +22% | +$75.7K | 0.01% | 517 |
|
|
2020
Q4 | $435K | Buy |
6,260
+2,486
| +66% | +$173K | 0.01% | 404 |
|
|
2020
Q3 | $917K | Buy |
3,774
+293
| +8% | +$71.2K | 0.03% | 218 |
|
|
2020
Q2 | $579K | Sell |
3,481
-932
| -21% | -$155K | 0.02% | 247 |
|
|
2020
Q1 | $299K | Buy |
4,413
+392
| +10% | +$26.6K | 0.01% | 308 |
|
|
2019
Q4 | $259K | Sell |
4,021
-555
| -12% | -$35.7K | 0.01% | 462 |
|
|
2019
Q3 | $266K | Buy |
4,576
+1,746
| +62% | +$101K | 0.01% | 316 |
|
|
2019
Q2 | $169K | Sell |
2,830
-1,484
| -34% | -$88.6K | 0.01% | 493 |
|
|
2019
Q1 | $281K | Sell |
4,314
-139
| -3% | -$9.05K | 0.01% | 267 |
|
|
2018
Q4 | $237K | Buy |
4,453
+1,920
| +76% | +$102K | 0.01% | 281 |
|
|
2018
Q3 | $145K | Buy |
2,533
+596
| +31% | +$34.1K | 0.01% | 291 |
|
|
2018
Q2 | $102 | Sell |
1,937
-67
| -3% | -$4 | 0.01% | 226 |
|
|
2018
Q1 | $96K | Buy |
2,004
+334
| +20% | +$16K | 0.01% | 292 |
|
|
2017
Q4 | $91K | Buy |
1,670
+384
| +30% | +$20.9K | 0.01% | 248 |
|
|
2017
Q3 | $79K | Buy |
1,286
+79
| +7% | +$4.85K | 0.01% | 149 |
|
|
2017
Q2 | $75K | Buy |
+1,207
| New | +$75K | 0.01% | 207 |
|